Baby formula can be a life saver in certain situations. Often the meal is expensive to manufacture and the facility itself can also be costly. Not to mention, FDA approval tends to be a waiting game for companies. But it’s an essential one at that to bring safe product to market.

Four companies control a majority of the U.S. production when it comes to infant formula, according to WCNC online. We have Abbott Nutrition, Nestle USA, Perrigo and Mead Johnson Nutrition.

But for the sake of this story, we have focused in on three noteworthy companies that make baby formula.

  1. Else Nutrition (TSX:BABY)
  2. Abbott Laboratories (NYSE:ABT)
  3. Nestle (OTC:NSRGY)

For full details, please watch the above video.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

Join the discussion: Find out what everybody’s saying about baby formula stocks, and check out other hot topics at Stockhouse’s stock forums and message boards.


More From The Market Online

@ the Bell: Markets rise on Iran–US peace hopes, SpaceX IPO biggest ever

Canadian equities advanced on Friday, supported by growing optimism that a peace agreement between Iran and...
microsoft xbox gamepass

Microsoft’s Xbox unit faces looming job cuts despite strong Showcase momentum

Microsoft’s (NASDAQ:MSFT) Xbox division is planning major layoffs and budget cuts expected after June 30 as part of a restructuring effort
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Results, awards, & upgrades

Aurora Cannabis Inc. (TSX/NASDAQ:ACB), a Canadian-based global medical cannabis company, reported its financial and operational results...
SpaceX’s Nasdaq debut could test investor appetite for AI-era mega-IPOs, with Anthropic and OpenAI also moving toward public listings.

SpaceX IPO tests investor appetite for AI mega-listings

SpaceX’s IPO could become the opening test for a new generation of AI-era mega-listings, with Anthropic and OpenAI preparing public-market debuts of their own.